Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 10 July 2027
- Last conf. stmt
- 26 June 2026
Pandeia Therapeutics Limited
- Incorporated
- 13 July 2018 (8 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Owned by
- Acadia Pharmaceuticals Inc.
- Accounts type
- Small
- Region
- East of England
- Address
- The Cambridge Partnership The Dorothy Hodgkin Bldg Babraham Research CampusBabrahamCambridgeCB22 3FH
Officers 2 active
Officer details are public data from the Companies House register.
American
Born April 1970 (56)
Corporate Secretary · Appointed 9 August 2019
Officer history (6 former)
26 April 2024
26 April 2024
Resigned Kim, Austin as Director
22 December 2022
22 December 2022
Appointed Kim, Austin as Director
22 December 2022
22 December 2022
19 September 2019
19 September 2019
19 September 2019
Resigned Quibell, Martin as Director
9 August 2019
30 July 2019
Resigned Schulz-Utermoehl, Timothy, Dr as Director
5 March 2019
Appointed Quibell, Martin as Director
5 March 2019
13 July 2018
Appointed Schulz-Utermoehl, Timothy, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Acadia Pharmaceuticals Inc.
Corporate entity · Notified 22 December 2022
Owns 75–100% of shares
Company
Former controllers (4)
22 December 2022
Ceased Medicxi Ventures I LP — Owns 75–100% of shares
20 September 2019
Ceased Timothy Schulz-Utermoehl — Owns 75–100% of shares
5 March 2019
Ceased Fraser Murray — Owns 25–50% of shares
5 March 2019
Ceased Martin Quibell — Owns 25–50% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£3,214,073)
- Cash
- £222,751
- Employees
- 1
- Debt Ratio
- 1289%
- Current Ratio
- 2.1x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £0 | £343 | £957 | £1,263 | £1,722 | £2,182 |
| Current Assets | £270,280 | £436,821 | £1,076,392 | £1,744,907 | £877,467 | £1,561,590 |
| Debtors | £47,529 | £258,204 | £280,123 | £219,023 | £513,110 | £175,664 |
| Cash | £222,751 | £178,617 | £796,269 | £1,525,884 | £364,357 | £1,385,926 |
| Creditors (< 1 year) | £127,853 | £161,786 | £247,747 | £116,338 | £134,111 | £157,043 |
| Creditors (> 1 year) | £3,356,500 | £1,570,800 | ||||
| Net Current Assets | £142,427 | £275,035 | £828,645 | £1,628,569 | £743,356 | £1,404,547 |
| Net Assets | (£3,214,073) | (£1,295,422) | ||||
| Shareholder Funds | (£3,214,073) | (£1,295,422) | £829,602 | £1,629,832 | £745,078 | £1,406,729 |
Filings
Filing history not loaded yet. See it on Companies House
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →